ClinicalTrials.govpublic full text
Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma
diffuse astrocytoma, idh-wildtype, recurrent glioblastoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 633733
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.